All In MedTech

Device Trial Radar · NCT04391803

EvaLuate EndoVascular Treatment of Acutely Ruptured Shallow Intradural Aneurysms With the Pipeline™ Flex Embolization Device With Shield TEchnology™ (ELEVATE)

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

25

Actual

Start

May 6, 2022

Primary completion

Oct 20, 2025

Study completion Oct 20, 2025

Sponsor

Sponsor type
Industry
First posted
May 18, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to assess the safety and effectiveness of the Pipeline™ Flex Embolization Device with Shield Technology™ in the treatment with acutely ruptured intracranial aneurysms.

Conditions

  • Intracranial Aneurysm
  • Ruptured Aneurysm

Interventions

  • Pipeline™ Flex Embolization Device with Shield Technology™Device

    The Pipeline™ Flex Embolization Device with Shield Technology™ is intended for endovascular treatment of adults with intracranial acutely ruptured aneurysms not amenable to clipping and coiling.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Complete Angiographic Occlusion Without Significant Stenosis, and no Rebleeding or Retreatment of the Target AneurysmTime frame: at 365-day
  2. Incidence of Neurological Death or Disabling Stroke Post-procedure.Time frame: at 365-day

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Yale New Haven Hospital

    New Haven, Connecticut

  • Wellstar Kennestone Hospital

    Marietta, Georgia

  • Rush University Medical Center

    Chicago, Illinois

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.